Story excerpt provided by Dayton Business Journal .
Written by Tristan Navera.
Biotechnology startups are getting more venture capital, experts are finding.
Numbers provided by Thomson Reuters found the amount of venture capital in the life sciences sector, which includes biotechnology and medical devices, reached $2.5 billion with 195 deals across the country in the second quarter of 2014. Those are the best numbers since 1995.
Click here to read the complete article.
Originally published September 3, 2014.